SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Follow-up) — Marilyn Monroe

PatientMarilyn Monroe
Date of birth1996-06-01
IdentifiersMRN HR-ML002-SYN; SSN (made up) 000-02-4471
Document date2026-09-14
AuthorJoanna Whitlock, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Three-month review on continuous hormonal treatment. [S]

History of Present Illness

Ms. Monroe returns three months after her first visit. She has taken the continuous pill daily and has had no periods, only a day or two of light spotting each month. Her worst pelvic pain in the past week was 4 of 10, from 8, she has used naproxen on two or three days a month, and she has missed no work for two months. Pain with deep intercourse persists and makes her tense up beforehand; bowel movements are no longer painful. The urine culture from her bladder infection grew Escherichia coli sensitive to nitrofurantoin, and her HPV, HIV and hepatitis C tests from the preventive visit were negative. She has had eight therapy sessions, sleeps seven hours without any sleep aid, and feels more like herself. She has had no thoughts of suicide or self-harm. [S]

ElementDetail
PainWorst 4 of 10, from 8; no missed work for two months
BleedingNo periods; light spotting a day or two a month
IntercourseDeep pain persists
ResultsUrine culture E. coli; HPV, HIV and hepatitis C negative
MoodPHQ-9 6, GAD-7 5; eight therapy sessions

Review of Systems

SystemResultFinding
GastrointestinalNegativeNo painful bowel movements; no stomach pain on naproxen
GenitourinaryPositiveDeep pain with intercourse; light spotting only; no urinary symptoms
NeurologicalNegativeNo migraine or visual aura
PsychiatricNegativeMood better; no thoughts of suicide or self-harm

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naproxen 500 mg oral tablet, one tablet by mouth twice daily with food, from two days before an expected bleed until the third day, and for pain flares; no more than 10 days a monthOne tablet by mouth twice daily with food when needed for pelvic painOral route2026-06-15activeS
Ethinyl estradiol 0.02 mg and norethindrone acetate 1 mg oral tablet, one tablet by mouth daily, taken continuously without a pill-free weekOne tablet by mouth daily, continuouslyOral route2026-06-15activeS
Nitrofurantoin (monohydrate and macrocrystals) 100 mg oral capsule, one capsule by mouth twice daily with food for 5 daysOne capsule by mouth twice daily with food for 5 daysOral route2026-07-20 to 2026-07-24completedS
Folic acid 0.4 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-08-17activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-09-14Body height166cmS
2026-09-14Body weight56.8kgS
2026-09-14Body mass index (BMI) [Ratio]20.6kg/m2S
2026-09-14Systolic blood pressure114mm[Hg]S
2026-09-14Diastolic blood pressure72mm[Hg]S
2026-09-14Heart rate72/minS
2026-09-14Respiratory rate14/minS
2026-09-14Body temperature36.6CelS
2026-09-14Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-09-14Hemoglobin [Mass/volume] in Blood12.8g/dL11.6-15 g/dLNormalS
2026-09-14Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
2026-09-14Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]5{score}S
2026-09-14Pain severity - 0-10 verbal numeric rating [Score] - Reported4{score}S

Physical Exam

Vital signs recorded on 2026-09-14; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 114/72, pulse 72; weight 56.8 kg
AbdomenSoft and non-tender
PelvicTight, tender levator ani muscles on both sides, worse on the left, that reproduce her pain with intercourse; mild left uterosacral tenderness, less than at diagnosis; no nodule; uterus mobile
PsychiatricBrighter and engaged; organized

Problems

ProblemClinical statusVerificationCodeProvenance
Severe painful periods since her teens, worse over the past three years, with pelvic pain between periods, deep pain with intercourse, and painful bowel movements during periods; she misses work for two or three days each cycle. Tender, slightly fixed retroverted uterus with tenderness and fullness in the left adnexa and along the left uterosacral ligament. Suspected endometriosis; transvaginal ultrasound and gynecology consultation bookedresolvedconfirmed N94.6S — Synthetic presenting problem linked to her documented endometriosis; superseded by the diagnosis at the consultation.
Endometriosis: a 3.4 cm left ovarian endometrioma on transvaginal ultrasound, with a tender, thickened left uterosacral ligament and no deep nodule of the bowel or bladder seen; diagnosed from imaging and examination without surgery, as the ESHRE guideline allows. Synthetic modern episode linked to her documented endometriosisactiveconfirmed N80.102S — Synthetic modern diagnosis made at the gynecology consultation; depth is unspecified because no surgery was done.
Major depressive disorder, single episode, moderate: about two months of low mood, poor sleep on painful nights, low energy, guilt about missed work, and poor concentration (PHQ-9 12, item 9 scored 0; GAD-7 8); Mood Disorder Questionnaire negative; no thoughts of suicide or self-harmactiveconfirmed F32.1S — Synthetic modern diagnosis; the historical and retrospective mental-health accounts are not coded.
Acute uncomplicated cystitis: one day of burning, frequency and urgency with suprapubic discomfort, without fever, flank pain or blood in the urine; urine dipstick positive for leukocyte esterase and nitrite; culture grew Escherichia coli sensitive to nitrofurantoin; resolvedresolvedconfirmed N30.00S — Synthetic acute infection; not a historical claim.
Pelvic floor muscle dysfunction with myofascial pain: deep pain with intercourse that persisted after three months of hormonal suppression, with tender, tight levator ani muscles that reproduce the pain on examinationactiveconfirmed M62.89S — Synthetic modern finding; a common companion of endometriosis pain.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyPelvic pain score (0 to 10), pain with intercourse and bowel movements, and missed working daysEvery visitCompleted todayWorst pain 4 of 10, from 8; deep pain with intercourse; no bowel pain; no missed work for two months
Self-managementBleeding pattern on continuous suppressionEvery visitCompleted todayNo periods; light spotting a day or two a month
Medication safetyCombined pill: adherence, side effects, and reasons to stop estrogen (migraine with aura, high blood pressure, clot symptoms, smoking)Every visit, with blood pressureCompleted todayTaken daily; blood pressure 114/72; no migraine with aura or clot symptoms
Medication safetyNaproxen: days used each month, and stomach or kidney symptomsEvery visitCompleted todayTwo or three days a month; no stomach pain
Medication safetyNo opioid, benzodiazepine, or sleep-medicine accumulation; prescription monitoring programAt the start, then every visit while pain is activeCompleted todayNo opioid, benzodiazepine or sleep medicine; prescription monitoring program checked today: no new prescriptions
LaboratoryHemoglobinAt baseline with heavy bleeding; again on treatmentCompleted today12.8 g/dL, from 12.2
ImagingTransvaginal ultrasound: endometrioma size and deep diseaseAt diagnosis; repeat at about four months on medical treatment, then yearly or if symptoms changeDueRepeat ultrasound booked before the next visit
ExaminationPelvic examinationAt diagnosis, and when pain persists or changesCompleted todayTender levator ani muscles reproduce her pain; uterosacral tenderness less
ReferralSurgical evaluation (laparoscopic excision)If pain does not respond to medical treatment, the cyst grows, or imaging is atypicalNot indicatedPain responding to medical treatment
ReferralPelvic floor physical therapyWhen pelvic floor muscle pain is foundReferredWeekly for six to eight weeks
Self-managementPregnancy intention and fertility planEvery visitCompleted todayStill planning a pregnancy in about a year; folic acid daily
SurveyDepression measure (PHQ-9)Monthly during acute treatment, every 2 to 4 weeks in continuation, then periodicallyDeferredPHQ-9 6 today, from 12 at intake and 8 at nine weeks. The PHQ-9 due about four weeks into treatment was not done: the only visit then was the sick visit for cystitis, and the measure was left for the preventive visit at nine weeks. No harm resulted: scores fell at each check and safety was reviewed at the sick visit. Corrective action: the behavioral health clinician records the PHQ-9 at each session and sends it to the chart
SurveyAnxiety measure (GAD-7)At diagnosis and with each depression measureCompleted todayGAD-7 5, from 8
SurveySuicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or self-harm; safety plan current
Self-managementCognitive behavioral therapy engagementWeekly for the first month, then every two weeksCompleted todayEight sessions
Self-managementSleep without sedativesEvery visitCompleted todaySeven hours without any sleep aid

Goal progress:

Immunizations given today: Influenza vaccine, 2026-2027 season [S]

Guideline basis: Practice Bulletin No. 114: Management of Endometriosis (2010); ESHRE guideline: endometriosis (2022); Chronic Pelvic Pain: ACOG Practice Bulletin, Number 218 (2020); CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022); U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 (2024); U.S. Selected Practice Recommendations for Contraceptive Use, 2024 (2024); Anxiety Disorders in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); Adult Immunization Schedule by Medical Condition and Other Indication (2026)

Follow-up: Pelvic floor physical therapy weekly. Transvaginal ultrasound in about five weeks, then a visit to review it, with the pain score, PHQ-9 and GAD-7. Next scheduled visit 2026-10-26: four-month review: pelvic floor physical therapy, follow-up ultrasound, mood, and pregnancy plans. [S]